Immunomodulation via Toll-like Receptor 9: An Adjunct Therapy Strategy against Alzheimer's Disease?

J Neurosci. 2017 May 10;37(19):4864-4867. doi: 10.1523/JNEUROSCI.0579-17.2017.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides
  • Animals
  • Cognition
  • Immunity, Innate
  • Immunomodulation
  • Mice
  • Toll-Like Receptor 9*

Substances

  • Amyloid beta-Peptides
  • Toll-Like Receptor 9